Relay Therapeutics Inc. (RLAY)
2.67
-0.05 (-1.84%)
At close: Mar 31, 2025, 3:40 PM
Relay Therapeutics Income Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| Revenue | 10.01M | 25.55M | 1.38M | 3.03M | 82.65M | n/a | n/a |
| Cost of Revenue | n/a | 5.27M | 4.13M | 3.92M | 3.55M | 2.85M | 2.15M |
| Gross Profit | 10.01M | 20.28M | -2.75M | -896K | 79.11M | -2.85M | -2.15M |
| Operating Income | -372.47M | -373M | -299.27M | -364.7M | -55.8M | -84.05M | -49.89M |
| Interest Income | 34.75M | 31.05M | 8.79M | 830K | 3.4M | 8.8M | 1.11M |
| Pretax Income | -337.71M | -341.97M | -290.51M | -363.87M | -52.41M | -75.31M | -48.78M |
| Net Income | -337.71M | -341.97M | -254.26M | -496.81M | -49.01M | -66.5M | -48.78M |
| Selling & General & Admin | 76.59M | 74.95M | 65.98M | 57.39M | 38.59M | 13.74M | 8.86M |
| Research & Development | 319.09M | 330.02M | 246.35M | 172.65M | 99.86M | 70.31M | 41.03M |
| Other Expenses | -13.21M | n/a | -20K | -4K | -16K | -58K | -9K |
| Operating Expenses | 382.48M | 398.55M | 312.33M | 230.04M | 138.45M | 84.05M | 49.89M |
| Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 382.48M | 398.55M | 312.33M | 230.04M | 138.45M | 84.05M | 49.89M |
| Income Tax | n/a | n/a | -36.25M | 132.94M | -3.4M | -8.8M | 1.1M |
| Shares Outstanding (Basic) | 142.87M | 122.58M | 112.23M | 95.14M | 42.62M | 4.28M | 2.49M |
| Shares Outstanding (Diluted) | 142.87M | 122.58M | 112.23M | 95.14M | 42.62M | 4.28M | 2.49M |
| EPS (Basic) | -2.36 | -2.79 | -2.27 | -5.22 | -1.15 | -15.53 | -19.63 |
| EPS (Diluted) | -2.36 | -2.79 | -2.27 | -5.22 | -1.15 | -15.53 | -19.63 |
| EBITDA | -380.21M | -374.15M | -306.82M | -222.18M | -52.25M | -81.2M | -47.73M |
| Depreciation & Amortization | 5.46M | 5.27M | 4.13M | 3.92M | 3.55M | 2.85M | 2.15M |